Experience of Treating a Young Patient With Primary Seminal Vesicle Adenocarcinoma

Clin Genitourin Cancer. 2018 Jun;16(3):e547-e552. doi: 10.1016/j.clgc.2018.02.008. Epub 2018 Feb 22.

Authors

Hongling Zhu¹, Huizhu Gan², Zhangzhen Shi¹, Yu Pei¹, Butong Sun¹

Affiliations

¹ Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.
² Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China. Electronic address: ganhuizhu2003@sina.com.

PMID: 29550197
DOI: 10.1016/j.clgc.2018.02.008

No abstract available

Keywords: Age; Chemotherapy; Diagnosis; SVA; Therapy.

Publication types

Case Reports

MeSH terms

Adenocarcinoma / diagnostic imaging
Adenocarcinoma / therapy*
Cisplatin / administration & dosage
Cisplatin / therapeutic use
Combined Modality Therapy / methods*
Etoposide / administration & dosage
Etoposide / therapeutic use
Genital Neoplasms, Male / diagnostic imaging
Genital Neoplasms, Male / therapy*
Humans
Male
Radiotherapy, Adjuvant
Seminal Vesicles / diagnostic imaging
Seminal Vesicles / pathology*
Tomography, X-Ray Computed
Treatment Outcome
Young Adult

Substances

Etoposide
Cisplatin